59. Collins, R., Yusuf, S. HPS —Simvastatin and anti-oxidants. American Heart
Association Scientific Sessions; November 11-14, 2001; Anaheim, California,
Plenary Session VII: Late - Breaking Clinical Trials.
60. Conti, J.V. The metabolic syndrome: is it really a syndrome? / J.V. Conti // Clin
Cardiol. - 2006. - Vol. 29 (1 2 ) .- P.523-524.
61. D Agostio, R.B. Primary and subsequent coronary risk appraisal: new result from
the Framingham Study / R.B. D Agostio, M.W. Russel, D.M. Huse // Am Heart J.
- 2 0 0 0 . -V o l . 139. - P.272-281.
62. De Baker, G. European guidelines on cardiovascular disease prevention in
clinical practice / G. De Baker, E. Ambrosioni, K. Borch-Jonsen, et al. // Eur J
Cardiovasc Prevention and Rehabil. - 2003. - Vol. 10 (Suppl. 1). - P.71-78.
63. De Graaf, J. Enhanced susceptibility to in vitro oxidation of the dense low
density lipoprotein subfraction in healthy subjects. / J. DeGraaf // Arterioscler
Thromb. - 1991. - Vol. 11. - P.298-306.
64. De Lorgeril. M. Mediterranean alpha-linolenic acid-rich diet in secondary
prevention of coronary heart disease / M. De Lorgeril, S. Renaud, N. Mamelle, et
al. // Lancet. - 1994. - S343. - P. 1454-1459.
65. Domanski M.J. Primary Prevention of Coronary Artery Disease / M.J.Domanski
//N Engl J Med.- 2 0 0 7 . -V o l . 357. - P.l 543-1545.
66. Downs, J.R. Primary prevention of acute coronary events with lovastatin in men
and women with average cholesterol levels: results of the AFCAPS/TexCAPS /
J.R. Downs, M. Clearfield, S. Weis, et al. // JAMA. - 1998. - Vol. 279. - P. 1615-
1622.
67. Dunn, A.L. Lifestyle physical activity interventions. History, short- and long
term effects and recommendations / A.L. Dunn, R.E. Anderson // Am J Prev
Med. - 1998.-V o l. 15. - P.398-412.
68. Durrington, P.N. Paraoxanase and atherosclerosis / P.N. Durrington, B.
Mackness, M.I. Mackness // Arterioscler Thromb Vase Biol. - 2001. - Vol. 21. -
P.473-480.
90
